Activation of Rac1 Promotes Hedgehog-Mediated Acquisition of the Myofibroblastic Phenotype in Rat and Human Hepatic Stellate Cells
Authors:
- Steve S. ChoiSCSteve S. Choi
- Rafal P. WitekRWRafal P. Witek
- Liu YangLYLiu Yang
- Alessia OmenettiAOAlessia Omenetti
- Wing-Kin SynWSWing-Kin Syn
- Cynthia A. MoylanCMCynthia A. Moylan
- Youngmi JungYJYoungmi Jung
- Gamze F. KaracaGKGamze F. Karaca
- Vanessa S. TeaberryVTVanessa S. Teaberry
- Thiago A. PereiraThiago A. Pereira
- Jiangbo WangJWJiangbo Wang
- Xiu-Rong RenXRXiu-Rong Ren
Open Access
- 23 June 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 52 (1) , 278-290
Abstract
Hepatic accumulation of myofibroblastic hepatic stellate cells (MF-HSCs) is pivotal in the pathogenesis of cirrhosis. Two events are necessary for MF-HSCs to accumulate in damaged livers: transition of resident, quiescent hepatic stellate cells (Q-HSCs) to MF-HSCs and expansion of MF-HSC numbers through increased proliferation and/or reduced apoptosis. In this study, we identified two novel mediators of MF-HSC accumulation: Ras-related C3 botulinum toxin substrate 1 (Rac1) and Hedgehog (Hh). It is unclear whether Rac1 and Hh interact to regulate the accumulation of MF-HSCs. We evaluated the hypothesis that Rac1 promotes activation of the Hh pathway, thereby stimulating signals that promote transition of Q-HSCs into MF-HSCs and enhance the viability of MF-HSCs. Using both in vitro and in vivo model systems, Rac1 activity was manipulated through adenoviral vector-mediated delivery of constitutively active or dominant-negative rac1. Rac1-transgenic mice with targeted myofibroblast expression of a mutated human rac1 transgene that produces constitutively active Rac1 were also examined. Results in all models demonstrated that activating Rac1 in HSC enhanced Hh signaling, promoted acquisition/maintenance of the MF-HSC phenotype, increased MF-HSC viability, and exacerbated fibrogenesis. Conversely, inhibiting Rac1 with dominant-negative rac1 reversed these effects in all systems examined. Pharmacologic manipulation of Hh signaling demonstrated that profibrogenic actions of Rac1 were mediated by its ability to activate Hh pathway-dependent mechanisms that stimulated myofibroblastic transition of HSCs and enhanced MF-HSC viability. Conclusion: These findings demonstrate that interactions between Rac1 and the Hh pathway control the size of MF-HSC populations and have important implications for the pathogenesis of cirrhosis. Hepatology 2010Keywords
This publication has 40 references indexed in Scilit:
- Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- Repair‐related activation of hedgehog signaling promotes cholangiocyte chemokine production†Hepatology, 2009
- Role for hedgehog pathway in regulating growth and function of invariant NKT cellsEuropean Journal of Immunology, 2009
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- Accumulation of Hedgehog-Responsive Progenitors Parallels Alcoholic Liver Disease Severity in Mice and HumansGastroenterology, 2008
- Epithelial–mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver diseaseLaboratory Investigation, 2008
- Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the LiverPhysiological Reviews, 2008
- Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cellsJournal of Hepatology, 2008
- Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in ratsGut, 2007
- Gli1 acts through Snail and E-cadherin to promote nuclear signaling by β-cateninOncogene, 2007